Fielder Capital Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$634K Sell
5,269
-4,298
-45% -$496K 0.14% 100
2025
Q4
$1.01M Buy
9,567
+5,641
+144% +$530K 0.21% 73
2025
Q3
$330K Buy
3,926
+773
+25% +$63.7K 0.08% 156
2025
Q2
$250K Sell
3,153
-171
-5% -$13.6K 0.07% 188
2025
Q1
$298K Sell
3,324
-623
-16% -$58.2K 0.09% 153
2024
Q4
$393K Buy
3,947
+2,107
+115% +$217K 0.12% 117
2024
Q3
$209K Sell
1,840
-175
-9% -$20.8K 0.07% 196
2024
Q2
$249K Buy
2,015
+4
+0.2% +$515 0.1% 145
2024
Q1
$265K Buy
+2,011
New +$248K 0.12% 122

Other funds holding MRK

Fielder Capital Group's MRK Position: Q1 2026 in Review

Fielder Capital Group reduced its Merck (MRK) stake by 45% in Q1 2026, selling an estimated $496K and leaving 5,269 shares worth $634K. The position accounts for 0.14% of the portfolio, ranked #100.

Fielder Capital Group first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.01M in Q4 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Fielder Capital Group held 5,269 shares of Merck worth $634K as of Q1 2026.
  • Fielder Capital Group sold 4,298 Merck shares in Q1 2026, an estimated $496K.
  • Merck made up 0.14% of Fielder Capital Group's portfolio in Q1 2026, its #100 holding.
  • Fielder Capital Group first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • Fielder Capital Group's Merck position peaked at $1.01M in Q4 2025.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Fielder Capital Group's 13F filing for Q1 2026, filed 12 May 2026.